Status:
NOT_YET_RECRUITING
A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants
Lead Sponsor:
IRCCS Ospedale San Raffaele
Conditions:
USH2A Variant Retinitis Pigmentosa
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the study is to perform a non-invasive multimodal retinal imaging investigation in a cohort of patients affected by USH2A retinitis pigmentosa (USH2A-RP), in order to develop a new diagnostic p...
Eligibility Criteria
Inclusion
- age \>18 years
- genetically confirmed diagnosis of USH2A-RP
- availability of genetic tests to assess the pathogenic variants
Exclusion
- inability to understand and sign the written informed consent form
- any inflammatory, infectious or degenerative eye disease
- media opacities resulting incompatible with good imaging quality
- uncontrolled systemic, metabolic, autoimmune neuroinflammatory and neurodegenerative disease
- ophthalmologic surgery within the previous six months
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06545253
Start Date
August 1 2024
End Date
February 1 2027
Last Update
August 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.